Eventide Asset Management »

Cerevel Therapeutics Hldng I shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $21M 490k 42.40
2023-09-30 $11M 490k 21.83
2023-06-30 $16M 490k 31.79
2023-03-31 $7.6M 312k 24.39